Abstract
Abstract only
- Title
- A randomized, double-blind phase III trial of niraparib maintenance treatment in patients with HRD+ advanced ovarian cancer after response to front-line platinum-based chemotherapy
- Creators
- Antonio Gonzalez-Martin - MD Anderson Cancer Center MadridFloor Jennishens Backes - The Ohio State UniversityKlaus H. Baumann - AGO & University in Marburg, Marburg, Germany;Dana Meredith Chase - University of ArizonaMathias Konrad Fehr - Kantonsspital FrauenfeldRobert L. Coleman - The University of Texas MD Anderson Cancer CenterGilles Freyer - Hôpital Lyon SudPaul DiSilvestro - Women & Infants Hospital of Rhode IslandOfer Lavie - Technion – Israel Institute of TechnologyThomas J. Herzog - University of CincinnatiDomenica Lorusso - Fondazione IRCCS Istituto Nazionale dei TumoriKathleen N. Moore - University of Oklahoma Health Sciences CenterMansoor Raza Mirza - Copenhagen University HospitalRoisin Eilish O'Cearbhaill - Memorial Sloan Kettering Cancer CenterIgnace Vergote - KU LeuvenBhavana Pothuri - New York UniversityJohn Balser - Veristat, Inc., Holliston, MA;Shefali Agarwal - TesaroBradley J. Monk - University of Arizona
- Publication Details
- Journal of clinical oncology, Vol.34(15_suppl), pp.TPS5606-TPS5606
- Identifiers
- 991005968880402656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article